Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 8/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.37 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.36 |
| ▸ | ABL1 | P00519 | 2/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.35 |
| ▸ | BCR | P11274 | 2/20 | 0.35 |
| ▸ | PELI1 | Q96FA3 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL565622 | 0.93 | GABRA1 (0.44) | ALOX5GABRA1GABRB2MAPTNPC1 | |
| Ether SCHEMBL565802 | 0.90 | ALOX5 (0.38) | ALOX5GABRA1GABRB2MAPTNPC1 | |
| SCHEMBL564433 | 0.87 | ALOX5 (0.46) | ALOX5GABRA1GABRB2MAPTESR1 | |
| SCHEMBL9240095 | 0.86 | KDM4E (0.41) | MAPTMEN1KMT2AHCAR3KDM4E | |
| SCHEMBL565803 | 0.86 | GAA (0.37) | ALOX5GABRA1GABRB2MAPTNPC1 | |
| SCHEMBL564768 | 0.86 | HSD17B1 (0.47) | GABRA1GABRB2ESR1ESR2HSD17B1 | |
| SCHEMBL564675 | 0.83 | GABRA1 (0.37) | GABRA1GABRB2MAPTNPC1POLB | |
| Ether SCHEMBL564674 | 0.83 | MAPT (0.39) | GABRA1GABRB2MAPTNPC1POLB | |
| SCHEMBL564660 | 0.79 | FFAR4 (0.36) | GABRA1GABRB2MAPTNPC1POLB | |
| SCHEMBL566048 | 0.79 | GABRA1 (0.48) | ALOX5GABRA1GABRB2MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8674029-B2 | Method of preparing stabilized polymeric systems using polymeric peroxides | Sunocs LLC (US) | 2014-03-18 | — | — | US | disclosed |
| US-20120035307-A1 | PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES | SONG CHENGQIAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-20120035315-A1 | METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES | SONG CHENGQIAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-7498467-B2 | Antioxidant and bisaminophenol derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20080161608-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-03 | — | — | US | disclosed |
| US-20060208227-A1 | Antioxidant and bisaminophenol derivative | IDEMITSU LOSAN CO., LTD (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1612254-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2006-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161608-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | CBR1, CBR3, HMOX1 | ALOX5 1446/4885GABRA1 1019/4885GABRB2 1083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.